During the past decade, Sonar Clinical Research conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Sonar Clinical Research" are "Alzheimer Disease" (1 trials) and "Sickle Cell Disease" (1 trials). Many other conditions were trialed in "Sonar Clinical Research" in a lesser frequency.

Most popular intervention types in "Sonar Clinical Research" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Etavopivat Tablets" (1 trials), "Etavopivat Tablets High dose" (1 trials), "Etavopivat Tablets Low dose" (1 trials), "Placebo" (1 trials) and "Placebo Tablets" (1 trials). Other intervention names were less common.

The vast majority of trials in "Sonar Clinical Research" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Sonar Clinical Research". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Sonar Clinical Research, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Sonar Clinical Research, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".